Will Pfizer keep us Iam scared !

[Anonymous]

But the device division should be ok, right? Pfizer doesn't have a device division, so the Hospira device folks should come out of this transition with their jobs in tact, don't you think?

IMHO I believe Pfizer will not keep the devices. It is too major a disruption to their way of operating as a pharmaceutical supplier. They would have to set up repair shops, training facilities, regulatory/FDA compliance departments, field service, etc. Most likely the business will be sold to another medical device company. Whether the Hospira device folks will retain their jobs depends on the company that will buy it.

IMHO if Pfizer is thinking of keeping the devices, then they should have people out at Hospira right now asking a lot of questions. If they aren't there, that means they have already made up their minds to sell it.

 

[Anonymous]

To be clear - Pfizer on cares about money. Actually $800M to be precise.

 

[Anonymous]

Well, we know they aren't keeping the folks from R&D sites that were let go today.

 

[Anonymous]

Well, we know they aren't keeping the folks from R&D sites that were let go today.

Then, IMHO Hospira made the decision for Pfizer: Pfizer will now have to sell the pump business.

 

[Anonymous]

Then, IMHO Hospira made the decision for Pfizer: Pfizer will now have to sell the pump business.

Shut up you troll Jack Ass

 

[Anonymous]

We had an all DC meeting this morning. The news was given to us
I couldn't concentrate and who knows how many errors I had today

i don't want to go in to the dc tomorrow. My pip is almost completed and one more error
or pod will get me fired. i don't like living like this. i feel like smashing something. my manager
is unfair and my comrades are unscrupulous backstabbers. is this normal behavior i feel like a stooge with this mickey mouse operation

 

[Anonymous]

i have to deal with a bull dike in the office pushing me to work harder and harder or else I'll get
scolded and written up again.

 

[Anonymous]

on second thought, maybe I want that back door visit.

 

[Anonymous]

i must go now someone's knocking on my back door.

 

[Anonymous]

can you believe somebody forcibly entered my back door and it's not even monday.

 

[Anonymous]

i have to deal with a bull dike in the office pushing me to work harder and harder or else I'll get
scolded and written up again.

give her a red lobster gift card and that roscoe special up dat Azz

 

[Anonymous]

when im done playin fleet version of solitaire; i will let my girl know .",

 

[Anonymous]

i m going fishing and bowling and i follow my nose wherever it goes.;,!

 

[Anonymous]

But the device division should be ok, right? Pfizer doesn't have a device division, so the Hospira device folks should come out of this transition with their jobs in tact, don't you think?

The devices should be fine most likely will be sold to another company, maybe even Baxter or it could be spun on it's own since it was reorged into a shadow company within Hospira with a Pres. CFO etc.
Another possibility would be for the acquisition to take place then once the dust settles it all gets spun again by Pfizer along with their hospital business with Ball still at the helm and new Hospira is born but the survivors coming mostly from Pfizer. Pfizer has been talking about splitting into 2 or 3 companies for a few yrs now. I read this in one of the large financial rags like Barrons, Crains etc. can't remember which.
But all in all the ones most likely to come out unhurt is DTS, keeping in mind that all top execs will do great. Sorry Ellen this does not mean you.

 

[Anonymous]

The devices should be fine most likely will be sold to another company, maybe even Baxter or it could be spun on it's own since it was reorged into a shadow company within Hospira with a Pres. CFO etc.
Another possibility would be for the acquisition to take place then once the dust settles it all gets spun again by Pfizer along with their hospital business with Ball still at the helm and new Hospira is born but the survivors coming mostly from Pfizer. Pfizer has been talking about splitting into 2 or 3 companies for a few yrs now. I read this in one of the large financial rags like Barrons, Crains etc. can't remember which.
But all in all the ones most likely to come out unhurt is DTS, keeping in mind that all top execs will do great. Sorry Ellen this does not mean you.

The future of the devices is in Costa Rica. In my opinion, that was always the plan. The pharma side of HSP was never comfortable running the medical device business and wanted to consolidate and transfer it as a single entity offshore. From the executives' point of view this makes sense because of the lower wages. Whether this idea succeeds or not, depends on the performance of the technical work force in CR and the stability of the supply chain.
The latter will influence the former. If CR succeeds in maintaining steady production for a prolonged period, then they will find a buyer. If not, Pfizer will be "stuck"with the medical devices, and in this case, some, not all of people who worked on the infusion pumps will be retained or rehired. But of course, they will most likely be under new management with possibly different and more demanding expectations than before.

Of course, this can all be pure conjecture based on false assumptions so do your own homework.

Good luck on your decision.

 

[Anonymous]

i must inform you pfe will sell off device division eventually.
do you all know hr man reported to Ken M.at one time

 

[Anonymous]

he was tight with weishaar,but not Ken M.who was from oliver wyman and free lanced for amgen among others.

 

[Anonymous]

including starbucks and novartis.

 

[Anonymous]

hr man freelanced after abbott seperation and was a 1090 contractor,thats how he can play his game on here and not be touched.

 

[Anonymous]

The devices should be fine most likely will be sold to another company, maybe even Baxter or it could be spun on it's own since it was reorged into a shadow company within Hospira with a Pres. CFO etc.
Another possibility would be for the acquisition to take place then once the dust settles it all gets spun again by Pfizer along with their hospital business with Ball still at the helm and new Hospira is born but the survivors coming mostly from Pfizer. Pfizer has been talking about splitting into 2 or 3 companies for a few yrs now. I read this in one of the large financial rags like Barrons, Crains etc. can't remember which.
But all in all the ones most likely to come out unhurt is DTS, keeping in mind that all top execs will do great. Sorry Ellen this does not mean you.

This is probably the smartest post on this thread yet. Think about it: we have had several product approvals with more on the way. It doesn't make sense to continue investing money in these things if there wasn't a future. The device business being spun is most likely with Endicott at the helm, not Ball. Mike will more than likely go lead another company that some other clown like Begley rode into the ground, repair it, sell it and then make another grip of money. There have been quite a few personnel changes within the device business over the past several months, changes that probably wouldn't have occurred if it was going to be gutted by PFE. Most namely, bringing in a new VP of Marketing from outside the company.